152 related articles for article (PubMed ID: 2731008)
1. 99mTc-nanocolloid bone marrow scintigraphy in prostatic cancer.
Haddock G; Gray HW; McKillop JH; Bessent RG; Kirk D
Br J Urol; 1989 May; 63(5):497-502. PubMed ID: 2731008
[TBL] [Abstract][Full Text] [Related]
2. Colloid scintigraphy showing red bone marrow extension in patients with prostatic carcinoma.
Rudberg U; Udén R; Ahlbäck SO
Acta Radiol; 1992 Mar; 33(2):97-102. PubMed ID: 1562417
[TBL] [Abstract][Full Text] [Related]
3. [Bone marrow scintigraphy using radiocolloids in bone metastases. Sensitivity, specificity, reliability and indications].
Fritz P; Adolph J; Bubeck B; Georgi P; zum Winkel K
Rofo; 1986 Jun; 144(6):689-95. PubMed ID: 3012705
[TBL] [Abstract][Full Text] [Related]
4. [The usefulness of bone marrow scintigraphy in the detection of bone metastasis from prostatic cancer].
Otsuka N; Fukunaga M; Morita R; Sone T; Yoneda M; Saito N; Tanaka H; Tomomitsu T; Yanagimoto S; Muranaka A
Kaku Igaku; 1985 Feb; 22(2):169-76. PubMed ID: 3159922
[No Abstract] [Full Text] [Related]
5. 99mTc-antigranulocyte bone marrow scintigraphy of breast and prostate skeletal metastases.
Limouris GS; Voliotopoulos V; Stavraka A; Vlahos L
Anticancer Res; 1997; 17(3B):1615-8. PubMed ID: 9179204
[TBL] [Abstract][Full Text] [Related]
6. Bone marrow scintigraphy in small cell carcinoma of the lung.
Li DJ; Maughan TS; Miles KA; Wraight EP
Nucl Med Commun; 1994 Jan; 15(1):29-33. PubMed ID: 8152690
[TBL] [Abstract][Full Text] [Related]
7. The usefulness of bone-marrow scintigraphy in the detection of bone metastasis from prostatic cancer.
Otsuka N; Fukunaga M; Sone T; Yoneda M; Saito N; Tanaka H; Tomomitsu T; Yanagimoto S; Muranaka A; Morita R
Eur J Nucl Med; 1985; 11(8):319-22. PubMed ID: 4076240
[TBL] [Abstract][Full Text] [Related]
8. Bone and bone marrow scintigraphy in the diagnosis of neoplastic involvement of the skeletal system. A comparative analysis.
Sacchi S; Marietta M; Rinaldi G; Pantusa M; Romani F; Zaniol P; Torelli U
J Nucl Med Allied Sci; 1987; 31(3):255-60. PubMed ID: 3694273
[No Abstract] [Full Text] [Related]
9. Bone marrow scintigraphy in prostatic carcinomas.
Bourgeois P; Malarme M; Van Franck R; Wauters G; Ferremans W
Nucl Med Commun; 1991 Jan; 12(1):35-45. PubMed ID: 2023692
[TBL] [Abstract][Full Text] [Related]
10. Clinical evaluation of the bone marrow imaging agent 99Tcm-phytate in the detection of bone metastases.
Chang CP; Liu RS; Yu SM; Wynchank S; Chu LS; Shiau HY; Cheng TC
Nucl Med Commun; 1996 Dec; 17(12):1030-4. PubMed ID: 9004298
[TBL] [Abstract][Full Text] [Related]
11. [Patterns of bone metastases of carcinoma of the prostate: evaluation using 99mTC-MDP bone scintigraphy].
Matsuda H; Sakashita S; Arakawa M; Koyanagi T
Nihon Hinyokika Gakkai Zasshi; 1987 Oct; 78(10):1809-13. PubMed ID: 3444173
[No Abstract] [Full Text] [Related]
12. Scintigraphy with nanocolloid Tc 99m in patients with small cell lung cancer, with special reference to bone marrow and hepatic metastasis.
Widding A; Stilbo I; Hansen SW; Hansen HH; Rossing N
Eur J Nucl Med; 1990; 16(8-10):717-9. PubMed ID: 2166669
[TBL] [Abstract][Full Text] [Related]
13. [Pathogenetic differentiation of the bone superscan using bone marrow scintigraphy].
Weckesser M; Müller-Mattheis VG; Vosberg H; Müller-Gärtner HW
Nuklearmedizin; 1998 Jun; 37(4):156-8. PubMed ID: 9650218
[TBL] [Abstract][Full Text] [Related]
14. Bone marrow scintigraphy in the diagnosis of post-traumatic avascular necrosis of bone.
Tawn DJ; Watt I
Br J Radiol; 1989 Sep; 62(741):790-5. PubMed ID: 2790419
[TBL] [Abstract][Full Text] [Related]
15. Gastrointestinal activity following bone marrow scintigraphy with technetium-99m nanocolloid in patients with multiple myeloma.
Agren B; Måre K; Aspelin P
Eur J Nucl Med; 1995 Nov; 22(11):1319-22. PubMed ID: 8575484
[TBL] [Abstract][Full Text] [Related]
16. Comparison of immunoscintigraphy and colloid scintigraphy of bone marrow.
Munz DL; Sandrock D; Rilinger N
Lancet; 1990 Jul; 336(8709):258-9. PubMed ID: 1973815
[No Abstract] [Full Text] [Related]
17. Preserved value of bone scintigraphy for the detection of skeletal metastases in prostate cancer patients with low prostate-specific antigen levels: effect of hormonal therapy and poor histologic differentiation.
Caglar M; Tuncel M
Clin Nucl Med; 2002 Jul; 27(7):532-3. PubMed ID: 12072787
[No Abstract] [Full Text] [Related]
18. The usefulness of 99mTc-HMPAO-labeled leukocyte scintigraphy in the diagnosis of skeletal metastases of cancers.
Kinoshita M; Imai Y; Fujiwara K; Miyamae T
Ann Nucl Med; 2000 Apr; 14(2):103-9. PubMed ID: 10830527
[TBL] [Abstract][Full Text] [Related]
19. Bone marrow immunoscintigraphy versus conventional bone scintigraphy in the diagnosis of skeletal metastases in urogenital malignancies.
Zoeller G; Sandrock D; Munz DL; Ringert RH
Eur Urol; 1994; 26(2):141-4. PubMed ID: 7957469
[TBL] [Abstract][Full Text] [Related]
20. [Comparison of skeletal scintigraphy and bone marrow scintigraphy in detection of osseous metastases].
Bathmann J; Moser E
Radiologe; 1995 Jan; 35(1):8-14. PubMed ID: 7892445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
